We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A coalition of drugmakers wants to boost performance at clinical trial sites by establishing common standards for good clinical practices and skill requirements for investigators. Read More
The FDA is taking a hard look at ways to bring early-stage device trials back to the U.S., hoping to reverse a decade-long trend that has seen companies moving them overseas. Read More